Advanced drug delivery technologies are reshaping cancer therapy by improving how and where anticancer drugs reach the tumor. Systems such as nanoparticles, liposomes, and polymer-based carriers allow targeted release of drugs directly into cancer tissues while minimizing damage to healthy cells. These technologies enhance drug stability, control release timing, and reduce systemic toxicity. Tumor-responsive delivery platforms can activate treatment only in the tumor environment, increasing precision. Overall, advanced delivery systems significantly improve treatment effectiveness and patient safety in modern oncology.